Malaria saved the lives of thousands of workers and helped develop the methods used in future public-health campaigns against the disease. The first effective treatment for malaria came from the bark of cinchona tree, which contains quinine. This tree grows on the slopes of the Andes, mainly in Peru. The indigenous peoples of Peru made a tincture of cinchona to control fever. Its effectiveness against malaria was found and the Jesuits introduced the treatment to Europe around 1640; by 1677, it was included in the London Pharmacopoeia as an antimalarial treatment. It was not until 1820 that the active ingredient, quinine,
Cinchona people. Italian sources spelt Quina as Cina which was a source of confusion with "Smilax" from China. Haggis argued that Qina and Jesuit's bark actually referred to "Myroxylon peruiferum" or Peruvian balsam and that this was an item of importance in Spanish trade in the 1500s. Over time, the bark of the "Myroxylon" was adulterated with the similar looking bark of what we now know as "Cinchona". Gradually the adulterant became the main product that was the key therapeutic ingredient used in malarial therapy. The bark was included as "Cortex Peruanus" in the London Pharmacopoeia in 1677. The "fever tree"